OTX-101

cyclosporine A 0.09% ophthalmic emulsion · Sun Pharmaceutical Industries Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OTX-101, covering 2018-12-14 to 2019-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca [Phase 3]